Condition
Keratopathy
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Unknown3
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04917562Completed
Refractive Transepithelial Photo-keratectomy (T-PKR) in High Myopia
NCT04251143Recruiting
Dresden Corneal Disease and Treatment Study
NCT04147390Phase 2UnknownPrimary
Immunosuppression After Repeat Keratoplasty
NCT03064984Not ApplicableUnknownPrimary
Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy
NCT01808378Phase 2UnknownPrimary
Stem Cells Treatment for Bilateral Limbic Associated Keratopathy (HULPOFT)
Showing all 5 trials